Page last updated: 2024-09-05

erlotinib and sb 220025

erlotinib has been researched along with sb 220025 in 3 studies

Compound Research Comparison

Studies
(erlotinib)
Trials
(erlotinib)
Recent Studies (post-2010)
(erlotinib)
Studies
(sb 220025)
Trials
(sb 220025)
Recent Studies (post-2010) (sb 220025)
22101802907

Protein Interaction Comparison

ProteinTaxonomyerlotinib (IC50)sb 220025 (IC50)
Chain A, MAP KINASE P38Homo sapiens (human)9.0095
Chain A, PROTEIN (MAP KINASE P38)Homo sapiens (human)9.0095
Chain A, PROTEIN (MAP KINASE P38)Homo sapiens (human)9.0095
Chain A, Protein (map Kinase P38)Homo sapiens (human)9.0095
Chain A, Extracellular Regulated Kinase 2Rattus norvegicus (Norway rat)9.0095
Chain A, Extracellular Regulated Kinase 2Rattus norvegicus (Norway rat)9.0095
Mitogen-activated protein kinase 13Homo sapiens (human)0.019
Mitogen-activated protein kinase 12Homo sapiens (human)0.019
Mitogen-activated protein kinase 1Rattus norvegicus (Norway rat)0.019
Mitogen-activated protein kinase 11Homo sapiens (human)0.019
Mitogen-activated protein kinase 14Homo sapiens (human)0.0193

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

3 other study(ies) available for erlotinib and sb 220025

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013